Home Featured 2

Featured 2

Featured posts

Most popular

Lung Cancer Global Mortality Projections Skyrocket for Women

lungcanc

Déjà Vu, With a Twist: The Vaping Industry’s Approach to Youth-Oriented Advertising Via Social Media

A Roadmap to Improving Lung Cancer Care in the Middle East and North Africa

The IASLC and the International Thoracic Oncology Nursing Forum: Celebrating Collaboration

Liquid Biopsy’s Role in Marker Identification: An Interview With Dr. Martin Filipits

Global Survey for Pathologists on PD-L1 Testing: Moving Toward Standardization

lungcanc

TTFields in Mesothelioma (The STELLAR Trial): More Stars Needed in the...

lungcanc

The IASLC Pathology Committee Recommendations for the Use of Diagnostic Immunohistochemistry...

lungcanc

Tumor Mutation Burden: Evolution of a Controversial Biomarker From the Pathologist’s...

lungcanc

Smoking Cessation After Cancer Diagnosis: A Neglected Problem

lungcanc

Ki-67 in Pulmonary Neuroendocrine Tumors: Where Do We Stand?

lungcanc

Artificial Intelligence in Lung Cancer: Opening New Avenues for Detection, Diagnosis,...

lungcanc

Smoking Cessation Prior to Lung Cancer Surgery

lungcanc

Lung Cancer in the Brazilian Health System: Screening, Drug Approvals, Barriers...

lungcanc

Financial Incentives and Free Treatment Aids for Smoking Cessation in the...

lungcanc

12 3...7 Page 1 of 7

Meeting News

Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation

Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib